News

Commercial-scale center will cost $650 million, featuring 144,000 liters of biomanufacturing capacity

Deal adds biopharma services to its capabilities

Will address biologics drug substance and drug product manufacturing services

Nominal revenue for US drug sales was up to $776 billion, reports IQVIA, but net revenue (discounting rebates) was $407 billion. Some $29 billion was spent on COVID-19 vaccines and therapeutics

Factory will reportedly provide capability of manufacturing 3-4 vaccines simultaneously

Biotech company hopes to tackle challenges surrounding therapeutics

PCSC Award is presented to supply chain security professionals “who have exhibited remarkable standards of honesty and integrity while working tirelessly to protect and serve their communities”

Expansion expected to double batch capacity

Acquisition works toward addressing needs of regenerative medicine industry

Includes 100,000 square feet of controlled ambient storage

Company has announced two updates regarding Nurtec ODT

North Carolina Collaboratory and SAS partnership using IoT analytics and sensor data from vaccine storage freezers to strengthen cold chain integrity and improve dosage delivery

Campus will feature a CDMO, over 1,000,000 square feet of floor space

New venture capital fund AB Health Ventures will partner with innovative startup companies in transforming healthcare

Global demand for the aforementioned month was greater than 2021, report shows

CDMO will invest up to $160 million toward manufacturing of therapies and vaccines, including mRNA

Product is powered by company’s Opus platform

Features growth of cold storage, visual inspections capacity

Reportedly provides 270 hours of independent runtime for temperature-sensitive pharma transportation

Collective project expected to enhance the manufacturing supply chain for ATMPs within the UK

The latest people news happenings over the past month

Action follows on the heels of Gilead’s court actions against a $250-million scheme

KTEvolution “can easily be carried by one or two people”

Will have capability of producing 300 million COVID-19 vaccines for Africa annually

Deal features $45 million for commercialization of several Big Pharma products

Trading partner Interconnections via the EPCIS standard is a basic requirement

Company builds on its sample accountability platform

Site construction is part of a 10-year agreement with the Australian government